Norcantharidin inhibits tumor growth and vasculogenic mimicry of human gallbladder carcinomas by suppression of the PI3-K/MMPs/Ln-5γ2 signaling pathway.
about
Evaluation of the correlation of vasculogenic mimicry, ALDH1, KAI1 and microvessel density in the prediction of metastasis and prognosis in colorectal carcinoma.Overexpression of Wnt5a promotes angiogenesis in NSCLC.A potential small-molecule synthetic antilymphangiogenic agent norcantharidin inhibits tumor growth and lymphangiogenesis of human colonic adenocarcinomas through blocking VEGF-A,-C,-D/VEGFR-2,-3 "multi-points priming" mechanisms in vitro and in vivIncarvine C suppresses proliferation and vasculogenic mimicry of hepatocellular carcinoma cells via targeting ROCK inhibition.Histone deacetylase 3 expression correlates with vasculogenic mimicry through the phosphoinositide3-kinase / ERK-MMP-laminin5γ2 signaling pathwayAnnexin A4-nuclear factor-κB feedback circuit regulates cell malignant behavior and tumor growth in gallbladder cancer.Norcantharidin inhibits Wnt signal pathway via promoter demethylation of WIF-1 in human non-small cell lung cancer.Evaluation of the correlation of vasculogenic mimicry, ALDH1, KiSS-1, and MACC1 in the prediction of metastasis and prognosis in ovarian carcinoma.Norcantharidin induces autophagy-related prostate cancer cell death through Beclin-1 upregulation by miR-129-5p suppression.Norcantharidin modulates miR-655-regulated SENP6 protein translation to suppresses invasion of glioblastoma cells.Ring finger protein 125, as a potential highly aggressive and unfavorable prognostic biomarker, promotes the invasion and metastasis of human gallbladder cancers via activating the TGF- β1-SMAD3-ID1 signaling pathway.Inhibitory effect of norcantharidin on melanoma tumor growth and vasculogenic mimicry by suppressing MMP-2 expressionOverview of advances in vasculogenic mimicry - a potential target for tumor therapy
P2860
Q33588908-CBCE15EF-168A-4D92-955D-6118E2CBEBBFQ33791918-A75B608E-AA6C-4C97-80A1-DE235BB3F718Q35695946-CE7BB5BB-4FE9-454B-B1C0-1A9C77720676Q35824952-C826FBB8-BF61-4731-88C2-0BD2E38977CEQ35904204-71B5FC57-689E-4401-B1CE-F99FA7D60C8DQ37153741-A128AF6C-F938-461F-AEA3-C444481144BEQ38894458-7547D819-26F3-4932-BE64-EA6E88319138Q38932894-89C79C56-146E-47A4-8A43-199A58575307Q40241247-CD30A592-4B85-46CE-B2BA-F11DA4B9D888Q40273812-1D5BC080-AFE3-4396-8DE2-7474801FF1F2Q41472817-2F1972FB-8101-4B00-9F05-9B6A4C849D98Q42290642-9FD154EB-02E0-4078-8973-D212F355D949Q58803491-554E67D3-89BB-4113-AC68-2478ED7E1E44
P2860
Norcantharidin inhibits tumor growth and vasculogenic mimicry of human gallbladder carcinomas by suppression of the PI3-K/MMPs/Ln-5γ2 signaling pathway.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Norcantharidin inhibits tumor ...... MMPs/Ln-5γ2 signaling pathway.
@ast
Norcantharidin inhibits tumor ...... MMPs/Ln-5γ2 signaling pathway.
@en
type
label
Norcantharidin inhibits tumor ...... MMPs/Ln-5γ2 signaling pathway.
@ast
Norcantharidin inhibits tumor ...... MMPs/Ln-5γ2 signaling pathway.
@en
prefLabel
Norcantharidin inhibits tumor ...... MMPs/Ln-5γ2 signaling pathway.
@ast
Norcantharidin inhibits tumor ...... MMPs/Ln-5γ2 signaling pathway.
@en
P2093
P2860
P356
P1433
P1476
Norcantharidin inhibits tumor ...... MMPs/Ln-5γ2 signaling pathway.
@en
P2093
Chun-Yan Ge
Jing-Tao Zhang
Wen-Zhong Zhang
Xing-Sui Lu
Yue-Zu Fan
Ze-Ming Zhao
Zhong-Yan Liu
P2860
P2888
P356
10.1186/1471-2407-14-193
P407
P577
2014-03-15T00:00:00Z
P5875
P6179
1022424699